Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic and NLR effects of etomidate, propofol, and ketamine during laryngoscopy
IRCT20160307026950N56Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, triple-blind trial of etomidate, propofol and ketamine (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Neutrophil-to-lymphocyte ratio. Started Dec 2023; status: completed.
02
Drugs
etomidatepropofolketamine
Beyond the preview
Go deeper on IRCT20160307026950N56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N56.